Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Multiple Sclerosis

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 12 articles:
HTML format
Text format



Single Articles


    April 2019
  1. MCCALL B
    Alemtuzumab to be restricted pending review, says EMA.
    Lancet. 2019;393:1683.
    PubMed     Text format    


    March 2018
  2. METZ LM, Liu WQ
    Effective treatment of progressive MS remains elusive.
    Lancet. 2018;391:1239-1240.
    PubMed     Text format    


  3. KAPPOS L, Bar-Or A, Cree BAC, Fox RJ, et al
    Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
    Lancet. 2018 Mar 22. pii: S0140-6736(18)30475.
    PubMed     Text format     Abstract available


  4. THOMPSON AJ, Baranzini SE, Geurts J, Hemmer B, et al
    Multiple sclerosis.
    Lancet. 2018 Mar 22. pii: S0140-6736(18)30481.
    PubMed     Text format     Abstract available


  5. THE LANCET
    End of the road for daclizumab in multiple sclerosis.
    Lancet. 2018;391:1000.
    PubMed     Text format    


    October 2017
  6. GREEN AJ, Gelfand JM, Cree BA, Bevan C, et al
    Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.
    Lancet. 2017 Oct 10. pii: S0140-6736(17)32346.
    PubMed     Text format     Abstract available


    March 2017
  7. ATKINS H, Freedman MS
    Immunoablation and aHSCT for aggressive multiple sclerosis - Authors' reply.
    Lancet. 2017;389:908.
    PubMed     Text format    


  8. HARRIS M, Cossburn M, Gregory R
    Immunoablation and aHSCT for aggressive multiple sclerosis.
    Lancet. 2017;389:907-908.
    PubMed     Text format    


    January 2017
  9. CHEN H, Kwong JC, Copes R, Tu K, et al
    Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study.
    Lancet. 2017 Jan 4. pii: S0140-6736(16)32399.
    PubMed     Text format     Abstract available


    November 2016
  10. COMI G, Radaelli M, Soelberg Sorensen P
    Evolving concepts in the treatment of relapsing multiple sclerosis.
    Lancet. 2016 Nov 23. pii: S0140-6736(16)32388.
    PubMed     Text format     Abstract available


  11. ONTANEDA D, Thompson AJ, Fox RJ, Cohen JA, et al
    Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function.
    Lancet. 2016 Nov 23. pii: S0140-6736(16)31320.
    PubMed     Text format     Abstract available


  12. BROWNLEE WJ, Hardy TA, Fazekas F, Miller DH, et al
    Diagnosis of multiple sclerosis: progress and challenges.
    Lancet. 2016 Nov 23. pii: S0140-6736(16)30959.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: